The No. 1* recommendation for non-melanoma skin cancer**

Eryfotona® AK Fluid is a medical device for the prevention and supportive treatment of actinic keratoses and non-melanoma skin cancer (NMSC).

Eryfotona® AK Fluid combines a very high sun protection factor (SPF 50+) with the DNA repair enzyme (photolyase). This helps prevent sun damage caused by sun exposure and supports the treatment of skin conditions.

What makes Eryfotona® AK special is that unique Repairsomes® form a protective layer on the skin, reducing the formation of new lesions.

With visible results after 3 months of treatment(2)

Regular application of Eryfotona® AK Fluid supports the natural DNA repair mechanism. This reduces sun-induced DNA damage to the skin by half, thus preventing the appearance of new lesions after photodynamic therapy.(4)

The enzyme photolyase contained in Eryfotona® AK sunscreen repairs DNA(3)

Sun exposure attacks skin cells and damages DNA. Healthy people can naturally repair 45% of this DNA damage to their skin.

Eryfotona® AK Sunscreen for Non-Melanoma Skin Cancer** contains unique DNA Repairsomes®, an ISDIN-patented technology that supports the body in repairing an additional 45% of this DNA damage. This effectively doubles the skin's ability to repair itself.

The sunscreen's texture becomes more fluid when shaken and melts into the skin. With a very high sun protection factor of 50+, it absorbs quickly and leaves a pleasant feeling on the skin. Suitable for all skin types.

*Based on the number of green prescriptions in the ATC3 (D02O sunscreen) market at pharmacies. As of MAT 08/2023, Pharmacy Sell-Out INSIGHT Health.

**non-melanocytic

(2) Phototype II with multiple lesions treated with AK-NMSC eryphoton twice daily over the entire cancer area.

(3) Stege H. et al. Enzymes plus light therapy to repair DNA damage in ultraviolet biradiated human skin. Proc Natl Acad Sci USA, 2000; 97(4): 1790-5. (4) Piaserico S. Cancerization field treatment with topical photolyase improves clinical outcomes after photodynamic therapy in patients with actinic keratosis: A prospective randomized intra-patient controlled pilot study. Sidemast 2012.8.

Application:

For non-melanoma skin cancer, apply sunscreen generously twice daily, morning and midday, to the entire affected area and other vulnerable, sun-exposed areas (face, forehead, ears, décolleté, bald head, and backs of hands). The photolyase effect is activated by visible light. For nighttime skincare, we recommend using Eryfotona Night to regenerate the skin.